{{getOldPrice()}}{{getPrice()}}
Without gluten
The major benefit of hawthorn is related to heart health, to improve symptoms related to cardiovascular diseases.
The major benefit of hawthorn is related to heart health, to improve symptoms related to cardiovascular diseases
Healthy, clean and dried leaves and flowers of Crataegus monogyna or Crataegus osycantha.
Leaves and flowers of Crataegus monogyna or Crataegus osycantha
Properties A) Flower: Diuretic, cardiotonic, hypotensive. A) Flower: Diuretic, cardiotonic, hypotensive
B) Herb: Diuretic, depurative, cardiotonic, antispasmodic, hypotensive. A) Flower: Diuretic, cardiotonic, hypotensive
Indications Heart rhythm disturbances, extrasystoles, paroxysmal tachycardia, palpitations, coronary inflammation, hypertension, arteriosclerosis, vascular spasms
In external use has healing properties, so it can be used in infected wounds, ulcers, stomatitis, eczema
Precautions High doses can produce cardiorespiratory depression USE Boil the equivalent of 1 cup of water. Remove from heat and pour 1.5 grams of Hawthorn. Cover and let stand for 10 minutes. DIt should be taken hot to maintain its properties. In addition, it is advisable to drink it in short sips to achieve the desired effect and enjoy its pleasant sweetish flavor
GROWING AND HARVESTING
PLANT PART: LEAVES PRESENTATION: CUTTING COUNTRY OF ORIGIN: BULGARIA CROP: BULGARIA COLLECTION: WILD WILDERNESS Collection: WILD
ORGANOLEPTIC CHARACTERISTICS CARACTERISTICS
COLOR: Green and cream SPELL: Characteristic Smell: Characteristic Smell: Characteristic
ASPECT: Correct FLAVOR: Correct CARACTERISTICS
FLAVOR: Characteristic FLAVOR: Characteristic FLAVOR: Characteristic
COMMUNITY DIRECTIVE 2006/142/EC ON INGREDIENTS AND ALLERGEN LABELLING According to the European Parliament and Council Directive 2006/142/EC on the labelling of foodstuffs In accordance with Directive 2003/89/EC the following is a list of allergenic ingredients that must be mentioned on the labeling for the purpose of consumer protection since the presence of these substances can cause allergies
ALESFRAMA, SL has an Allergen Management System according to Regulations 609/13 and 1169/2011
*(1) ALLERGEN *(1) ALLERGEN: That which is found in the product as part of its composition
*(2) ALLERGENINDIRECT: One that may appear in the product as a result of cross-contamination. *(2) ALLERGEN: One that may appear in the product as a result of cross-contamination
*(3)Absence: When the product neither contains, nor can contain, in any way the allergen from our supplier's facilities. (3)Absence: When the product neither contains, nor can contain, in any way the allergen from our supplier's facilities
ALLERGENIC DIRECT (1) INDIRECT (2) Absence (3) Gluten (wheat and derivatives) X Gluten (rye and derivatives) X Gluten (barley and derivatives) X Gluten (oats and oatmeal derivatives) X Gluten (spelt and derivatives) X Gluten (kamut and derivatives) X Crustaceans and crustacean products X Eggs and egg-based products X Fish and fish products X Peanuts and peanut-based products X Soy and soy-based products X Milk and milk products (including lactose) X Almonds and products thereof X Hazelnuts and derived products X Nuts and derived products X Cashew nuts and cashew products X Pacanas and derivative products X Pará chestnuts and derived products X Pistachios and derived products X Macadamias and derived products X Copium and derived products X Mustard and products thereof X Sesame seeds and products based on sesame seeds X Sulfur dioxide and sulfites X Lupins and lupin-based products X Molluscan shellfish and shellfish products X FURTHER INFORMATION Declaration GMO This product has been produced from non-GMO raw materials, complying with the requirements of the GMO Legislation in force in the EU, so its use does not require additional labeling
Irradiation This product has not been subjected to any type of ionizing radiation
Packagingand packaging ALESFRAMA, SL uses only food-compliant containers and packaging
Pesticides
Our supplier has established in its Quality System the control of pesticides and PHA's in compliance with the current EU legislation